Investment Objective: Picard Medical, Inc. is an investment vehicle focused on the Healthcare sector in US. It is currently trading at 9.48 USD.
Strategy: Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human …
Income: This appears to be an accumulating fund (dividends are reinvested) or focuses purely on capital growth.
No, it does not currently pay a dividend.
Picard Medical, Inc. is classified as a Fund. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be Nov. 13, 2026.
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.
| Split Date | Split Ratio to 1 |
|---|---|
| Aug. 3, 2026 | 1:50 |
Community Discussion